4//SEC Filing
Chrousos Phaedra 4
Accession 0000950170-24-064669
CIK 0001347178other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:43 PM ET
Size
7.0 KB
Accession
0000950170-24-064669
Insider Transaction Report
Form 4
Chrousos Phaedra
Director
Transactions
- Award
Common Stock
2024-05-22+21,887→ 64,125 total - Award
Stock Option (right to buy)
2024-05-22+40,202→ 40,202 totalExercise: $5.14Exp: 2034-05-21→ Common Stock (40,202 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 22, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
- [F2]This option vests and becomes exercisable with respect to 100% of the option shares on May 22, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001774518
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 4:43 PM ET
- Size
- 7.0 KB